静脉注射免疫球蛋白治疗重症肌无力
Intravenous immune globulin in myasthenia gravis.
作者信息
Gajdos P
机构信息
Service de Réanimation Médicale, Hôpital Raymond Poincaré, Garches, France.
出版信息
Clin Exp Immunol. 1994 Jul;97 Suppl 1(Suppl 1):49-51.
Abstract
Myasthenia gravis (MG) is an autoimmune disease of neuromuscular transmission associated with the presence of anti-acetylcholine receptor antibodies (anti-AChR Ab). Current treatment of MG includes anti-cholinesterase drugs, thymectomy, corticosteroids, immunosuppressants and plasma exchange (PE). The use of intravenous immune globulin (IVIG) in MG was proposed 10 years ago. Published results of IVIG treatment are discussed and the need for a controlled study is emphasized.
摘要
重症肌无力（MG）是一种与抗乙酰胆碱受体抗体（抗AChR Ab）存在相关的神经肌肉传递自身免疫性疾病。MG的当前治疗方法包括抗胆碱酯酶药物、胸腺切除术、皮质类固醇、免疫抑制剂和血浆置换（PE）。静脉注射免疫球蛋白（IVIG）用于MG的治疗是10年前提出的。本文讨论了IVIG治疗已发表的结果，并强调了进行对照研究的必要性。
相似文献
1
Intravenous immune globulin in myasthenia gravis.静脉注射免疫球蛋白治疗重症肌无力
Clin Exp Immunol. 1994 Jul;97 Suppl 1(Suppl 1):49-51.
2
[Antibodies in myasthenia gravis].[重症肌无力中的抗体]
Rev Neurol (Paris). 2009 Feb;165(2):137-43. doi: 10.1016/j.neurol.2008.11.020. Epub 2009 Jan 21.
3
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.全身血清反应阴性重症肌无力患者中抗肌肉特异性激酶抗体的临床相关性
Brain. 2003 Oct;126(Pt 10):2304-11. doi: 10.1093/brain/awg223. Epub 2003 Jun 23.
4
Management of myasthenia gravis.重症肌无力的管理
Am J Ther. 2005 May-Jun;12(3):262-8.
5
Therapeutic options in autoimmune myasthenia gravis.自身免疫性重症肌无力的治疗选择
Autoimmun Rev. 2007 Jun;6(6):373-8. doi: 10.1016/j.autrev.2007.01.001. Epub 2007 Jan 30.
6
Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.一名既往血清学阳性的重症肌无力患儿胸腺切除术后的抗肌自身抗体
Neurology. 2007 Aug 21;69(8):803-4. doi: 10.1212/01.wnl.0000267694.45244.f4.
7
Development of novel therapies for MG: Studies in animal models.开发治疗重症肌无力的新疗法：动物模型研究。
Autoimmunity. 2010 Aug;43(5-6):446-60. doi: 10.3109/08916930903518081.
8
[Contribution of intravenous immunoglobulins to the treatment of myasthenia].静脉注射免疫球蛋白在重症肌无力治疗中的作用
Ann Med Interne (Paris). 2000 May;151 Suppl 1:1S30-4.
9
[A case of myasthenia gravis with anti-MuSK antibodies showing a dramatic improvement with plasma exchange].1例抗肌肉特异性激酶（MuSK）抗体阳性重症肌无力患者经血浆置换后显著改善
Rinsho Shinkeigaku. 2005 Jul;45(7):510-3.
10
[Therapeutic strategy in myasthenia gravis].[重症肌无力的治疗策略]
Rev Neurol (Paris). 2009 Feb;165(2):149-54. doi: 10.1016/j.neurol.2009.01.005.
引用本文的文献
1
Intravenous immunoglobulin treatment in chronic neurological diseases: do we have maintenance dose right?慢性神经疾病中的静脉注射免疫球蛋白治疗：我们确定维持剂量正确吗？
Autoimmune Dis. 2014;2014:962530. doi: 10.1155/2014/962530. Epub 2014 Dec 18.
2
[Therapeutic plasma exchange 1996].[治疗性血浆置换 1996年]
Med Klin (Munich). 1997 Oct 15;92(10):615-20. doi: 10.1007/BF03044789.
3
Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.静脉注射免疫球蛋白治疗伴抗神经元自身抗体的副肿瘤性神经系统综合征。
J Neurol Neurosurg Psychiatry. 1996 Apr;60(4):388-92. doi: 10.1136/jnnp.60.4.388.
4
Intravenous immunoglobulin treatment in neurological diseases.神经疾病的静脉注射免疫球蛋白治疗
J Neurol Neurosurg Psychiatry. 1996 Apr;60(4):359-61. doi: 10.1136/jnnp.60.4.359.
本文引用的文献
1
Controversies about the treatment of myasthenia gravis.重症肌无力治疗方面的争议。
J Neurol Neurosurg Psychiatry. 1980 Jul;43(7):644-59. doi: 10.1136/jnnp.43.7.644.
2
Opinions about plasma exchange and associated treatments in the therapy of myasthenia gravis.关于血浆置换及相关治疗在重症肌无力治疗中的观点。
Muscle Nerve. 1983 Jul-Aug;6(6):457-8. doi: 10.1002/mus.880060611.
3
High-dose intravenous gammaglobulin for myasthenia gravis.大剂量静脉注射丙种球蛋白治疗重症肌无力
Lancet. 1984 Apr 14;1(8381):848-9. doi: 10.1016/s0140-6736(84)92294-3.
4
High-dose intravenous gammaglobulin for myasthenia gravis.大剂量静脉注射丙种球蛋白治疗重症肌无力
Lancet. 1984 Feb 18;1(8373):406-7. doi: 10.1016/s0140-6736(84)90469-0.
5
Myasthenia gravis and myasthenic syndromes.重症肌无力和肌无力综合征。
Ann Neurol. 1984 Nov;16(5):519-34. doi: 10.1002/ana.410160502.
6
High-dose intravenous immunoglobulin in the management of myasthenia gravis.大剂量静脉注射免疫球蛋白治疗重症肌无力
Arch Intern Med. 1986 Jul;146(7):1365-8.
7
Effects of repeated doses of intravenous immunoglobulin in myasthenia gravis.静脉注射免疫球蛋白重复给药对重症肌无力的影响。
Am J Med Sci. 1988 May;295(5):438-43. doi: 10.1097/00000441-198805000-00005.
8
Plasma C3c changes in myasthenia gravis patients receiving high-dose intravenous immunoglobulin during crisis.重症肌无力患者在危象期间接受大剂量静脉注射免疫球蛋白时血浆C3c的变化。
Acta Neurol Scand. 1989 Oct;80(4):324-6. doi: 10.1111/j.1600-0404.1989.tb03887.x.
9
Treatment of myasthenia gravis with high-dose intravenous immunoglobulin.大剂量静脉注射免疫球蛋白治疗重症肌无力
Acta Neurol Scand. 1991 Aug;84(2):81-4. doi: 10.1111/j.1600-0404.1991.tb04912.x.
10
Intravenous gamma-globulin in myasthenia gravis: interaction with anti-acetylcholine receptor autoantibodies.静脉注射丙种球蛋白治疗重症肌无力：与抗乙酰胆碱受体自身抗体的相互作用
J Clin Immunol. 1991 May;11(3):128-31. doi: 10.1007/BF00918680.
Zotero 插件